Reviewing Thermo Fisher Scientific (TMO) and Zeltiq Aesthetics (ZLTQ)
Thermo Fisher Scientific (NYSE: TMO) and Zeltiq Aesthetics (NASDAQ:ZLTQ) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.
Earnings & Valuation
This table compares Thermo Fisher Scientific and Zeltiq Aesthetics’ revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Thermo Fisher Scientific||$18.27 billion||4.22||$2.02 billion||$5.89||32.64|
Thermo Fisher Scientific has higher revenue and earnings than Zeltiq Aesthetics. Zeltiq Aesthetics is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.
This table compares Thermo Fisher Scientific and Zeltiq Aesthetics’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Thermo Fisher Scientific||11.73%||15.94%||7.41%|
This is a breakdown of current recommendations and price targets for Thermo Fisher Scientific and Zeltiq Aesthetics, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Thermo Fisher Scientific||0||1||14||0||2.93|
Thermo Fisher Scientific presently has a consensus target price of $204.46, indicating a potential upside of 6.34%. Zeltiq Aesthetics has a consensus target price of $56.83, indicating a potential upside of 0.63%. Given Thermo Fisher Scientific’s stronger consensus rating and higher probable upside, analysts plainly believe Thermo Fisher Scientific is more favorable than Zeltiq Aesthetics.
Thermo Fisher Scientific pays an annual dividend of $0.60 per share and has a dividend yield of 0.3%. Zeltiq Aesthetics does not pay a dividend. Thermo Fisher Scientific pays out 10.2% of its earnings in the form of a dividend.
Institutional & Insider Ownership
86.2% of Thermo Fisher Scientific shares are held by institutional investors. 0.5% of Thermo Fisher Scientific shares are held by company insiders. Comparatively, 15.6% of Zeltiq Aesthetics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Thermo Fisher Scientific beats Zeltiq Aesthetics on 8 of the 12 factors compared between the two stocks.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables. The Analytical Instruments segment provides a range of instruments, consumables, software and services. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers controlled temperature technologies products, growth protection and separation products, and water and laboratory products.
About Zeltiq Aesthetics
ZELTIQ Aesthetics, Inc. is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company’s product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians. It also offers consumables, which are CoolSculpting procedure packs that are needed to perform procedures using its CoolSculpting system. CoolSculpting is a non-invasive fat reduction procedure. CoolSculpting utilizes its controlled cooling technology to selectively reduce stubborn fat bulges. The CoolSculpting system includes CoolSculpting control unit and CoolSculpting applicators. The CoolSculpting Applicator delivers vacuum suction and cooling to the fat bulge being treated.
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with Analyst Ratings Network's FREE daily email newsletter.